PetMeds® Press Releases
1-800-PETMEDS ANNOUNCES THIRD QUARTER FINANCIAL RESULTS
Pompano Beach, Florida, January 24, 2005 - PetMed Express, Inc. (NASDAQ: PETS) today announced results for the quarter ended December 31, 2004. Net sales for the three months ended December 31, 2004 were $20.8 million, compared to $17.2 million for the three months ended December 31, 2003, an increase of 21%. Net income was $2.0 million, or $.08 diluted per share, for the quarter ended December 31, 2004, compared to $1.2 million, or $.05 diluted per share, for the quarter ended December 31, 2003, an increase to net income of 60%. Net sales for the nine months ended December 31, 2004 were $84.8 million, compared to $72.5 million for the nine months ended December 31, 2003, an increase of 17%. Net income was $5.6 million, or $.23 diluted per share, for the nine month period, compared to net income of $4.5 million or $.19 diluted per share, for the same period a year ago, an increase to net income of 25%.
Mendo Akdag, CEO, commented: “Our reorder sales increased 27%, from $11.4 million to $14.5 million for the three months ended
December 31, 2003 and 2004, and our reorder sales increased 40%, from $36.8 million to $51.7 million for the nine months ended
December 31, 2003 and 2004, respectively. We also acquired approximately 85,000 new customers in the quarter and approximately
430,000 new customers for the nine month period, and approximately 53% of all orders were placed on our website for the quarter.”
Founded in 1996, PetMed Express is America’s largest pet pharmacy, delivering prescription and non-prescription pet medications
and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number
and on the Internet through its website at www.1800petmeds.com.
This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2004. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.
For investment relations contact PetMed Express, Inc., Pompano Beach, Bruce S. Rosenbloom, CFO, 954-979-5995.